Background: The recent inclusion of the pediatric population aged 12-17 years old in the rollout of COVID-19 vaccines in the country is necessary in order to increase vaccine coverage, and eventually achieve herd immunity. Vaccination of those in this age group is dependent on the vaccine acceptance of their parents or respective caregivers. Objective: The study’s primary aim was to determine factors associated with parents’ intent to vaccinate their children against COVID-19. Specifically, this study aims to determine: 1. parent and child factors that influence the parents willingness to have their children vaccinated, 2. external factors in the decision to vaccinate their children, that is, if it is recommended by the doctor or school, and 3. concerns of parents regarding vaccination Methods: A multi-clinic cross-sectional analytic study design was used. Respondents were parents in select Healthway Family Clinics in Cavite. Data were gathered via self-administered questionnaires, adapted and modified with permission from the authors of The COVID States Project. Data were analyzed using Epi Info 7. Results: Among 350 respondents, 73.71% are most likely to vaccinate their children against COVID-19 once the vaccine becomes available to them. The major parental concerns are: long term health effects (56.29%), whether it has been tested enough (54.86%), immediate side effects (54.57%), and whether the vaccine actually works (54%). There is an association between the willingness of parents to vaccinate their children with the age and COVID-19 vaccination status of parent, and age and EPI immunization status of the child. Parents consider doctors’ and school’s recommendations to be very important factors in their decision to vaccinate their children Conclusion Majority of participants are likely to have their children vaccinated. Knowledge of associated factors and parental concerns gives the researchers better understanding of vaccine hesitancy amongst parents. This is vital to promote vaccination in the clinic setting, and on a much larger scale, in the local and national government’s public health strategies.
COVID-19 Vaccines